Insider · CIK 0001268854
SAUNDERS BRENT L
Reports to the SEC for 8 companies · VAUGHAN
Transactions
50
Companies
8
Filings
14
CIK
0001268854
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-08-05 | BLCOBausch & Lomb CorpF Tax Payment | −$70.9K |
| 2026-08-05 | BLCOBausch & Lomb CorpA Award | — |
| 2026-06-24 | SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2026-05-22 | BLCOBausch & Lomb CorpF Tax Payment | −$45.9K |
| 2026-03-06 | BLCOBausch & Lomb CorpP Purchase | +$252K |
| 2026-03-06 | BLCOBausch & Lomb CorpA Award | — |
| 2026-02-27 | BLCOBausch & Lomb CorpF Tax Payment | −$451K |
| 2026-02-26 | BLCOBausch & Lomb CorpF Tax Payment | −$408K |
| 2026-02-25 | BLCOBausch & Lomb CorpA Award | — |
| 2026-02-23 | BLCOBausch & Lomb CorpF Tax Payment | −$1.18M |
| 2025-08-05 | BLCOBausch & Lomb CorpF Tax Payment | −$61.1K |
| 2025-07-21 | BLCOBausch & Lomb Corp · Performance Stock UnitsA Award | — |
| 2025-06-25 | SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2025-06-16 | SKINSkinHealth Systems Inc.A Award | — |
| 2025-05-22 | BLCOBausch & Lomb CorpP Purchase | +$248K |
| 2025-05-22 | BLCOBausch & Lomb CorpA Award | — |
| 2025-05-20 | SPRYARS Pharmaceuticals, Inc.M Exercise/Conversion | +$121K |
| 2025-05-20 | SPRYARS Pharmaceuticals, Inc.S Sale | −$1.71M |
| 2025-05-20 | SPRYARS Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2025-02-26 | BLCOBausch & Lomb CorpA Award | — |
| 2025-02-26 | BLCOBausch & Lomb Corp · Non-Qualified Stock Options (right to purchase)A Award | — |
| 2024-12-23 | BLCOBausch & Lomb CorpF Tax Payment | −$1.32M |
| 2024-12-23 | BLCOBausch & Lomb CorpF Tax Payment | −$439K |
| 2024-08-12 | SKINSkinHealth Systems Inc.P Purchase | +$43.7K |
| 2024-08-05 | BLCOBausch & Lomb CorpP Purchase | +$505K |
| 2024-08-05 | BLCOBausch & Lomb CorpA Award | — |
| 2024-07-08 | SKINSkinHealth Systems Inc.A Award | — |
| 2024-06-20 | SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2024-02-28 | BLCOBausch & Lomb CorpA Award | — |
| 2024-02-28 | BLCOBausch & Lomb Corp · Non-Qualified Stock Options (right to purchase)A Award | — |
| 2023-08-16 | SKINSkinHealth Systems Inc.P Purchase | +$362K |
| 2023-06-27 | SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award | — |
| 2023-06-14 | SKINSkinHealth Systems Inc.A Award | — |
| 2023-02-03 | SKINSkinHealth Systems Inc.F Tax Payment | −$175K |
| 2022-12-30 | SKINSkinHealth Systems Inc.F Tax Payment | −$19.7K |
| 2022-12-08 | CSCOCISCO SYSTEMS, INC.A Award | — |
| 2022-11-08 | SPRYARS Pharmaceuticals, Inc. · Stock option (right to buy)A Award | — |
| 2022-11-08 | SPRYARS Pharmaceuticals, Inc. · Stock option (right to buy)A Award | — |
| 2022-09-30 | SKINSkinHealth Systems Inc.F Tax Payment | −$25.5K |
| 2022-06-30 | SKINSkinHealth Systems Inc.F Tax Payment | −$39.6K |
| 2022-06-22 | BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award | — |
| 2022-03-31 | SKINSkinHealth Systems Inc.F Tax Payment | −$62.6K |
| 2022-02-04 | SKINSkinHealth Systems Inc.A Award | — |
| 2022-02-04 | SKINSkinHealth Systems Inc.A Award | — |
| 2022-01-27 | SKINSkinHealth Systems Inc.F Tax Payment | −$83.4K |
| 2021-12-29 | BBIOBridgeBio Pharma, Inc.P Purchase | +$255K |
| 2021-12-13 | CSCOCISCO SYSTEMS, INC.A Award | — |
| 2021-09-10 | SKINSkinHealth Systems Inc.A Award | — |
| 2021-09-10 | SKINSkinHealth Systems Inc. · Performance Restricted Stock UnitsA Award | — |
| 2021-06-17 | BBIOBridgeBio Pharma, Inc. · Stock Option (right to buy)A Award | — |
Recent filings
- 4SAUNDERS BRENT L0001860742-26-000089SEC(opens sec.gov)
- 4SAUNDERS BRENT L0001268854-26-000002SEC(opens sec.gov)
- 4SAUNDERS BRENT L0001860742-26-000071SEC(opens sec.gov)
- 4SAUNDERS BRENT L0001860742-26-000054SEC(opens sec.gov)
- 4SAUNDERS BRENT L0001860742-26-000041SEC(opens sec.gov)
- 4SAUNDERS BRENT L0001860742-26-000028SEC(opens sec.gov)
- 4SAUNDERS BRENT L0001860742-26-000027SEC(opens sec.gov)
- 4SAUNDERS BRENT L0001127602-25-020237SEC(opens sec.gov)
- 4SAUNDERS BRENT L0000950170-25-097980SEC(opens sec.gov)
- 4SAUNDERS BRENT L0001415889-25-018384SEC(opens sec.gov)
- 4SAUNDERS BRENT L0001628280-25-032141SEC(opens sec.gov)
- 4SAUNDERS BRENT L0001127602-25-015582SEC(opens sec.gov)
- 4SAUNDERS BRENT L0001415889-25-014185SEC(opens sec.gov)
- 4SAUNDERS BRENT L0001127602-25-007260SEC(opens sec.gov)
Companies
- Allergan plcDirector, Chairman, President and CEO
- ARS Pharmaceuticals, Inc.DirectorSPRY
- Bausch & Lomb CorpDirector, Chairman of the Board and CEOBLCO
- BridgeBio Pharma, Inc.DirectorBBIO
- CISCO SYSTEMS, INC.DirectorCSCO
- Forest Laboratories, LLCDirector, CEO & President
- Merck & Co., Inc.Senior Vice PresidentMRK
- SkinHealth Systems Inc.Director, ChairmanSKIN
Address
C/O BAUSCH + LOMB CORPORATION 520 APPLEWOOD CRESCENT
VAUGHAN, L4K 4B4